Autistic adults had up to 8x dementia rates in research Anavex cites
Anavex Life Sciences announced new scientific findings linking autism spectrum disorder (ASD) and Alzheimer’s disease (AD) through shared biological mechanisms like autophagy dysfunction and synaptic pruning deficits. The company cites epidemiological research indicating autistic adults may have up to 8 times higher dementia rates. These findings support Anavex's intent to advance blarcamesine, a SIGMAR1 activator, into pivotal clinical studies, building on its demonstrated effects in previous trials for Alzheimer's, Rett syndrome, and Parkinson's disease dementia.